Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types

Abstract Methylation of RNA and DNA, notably in the forms of N6-methyladenosine (m6A) and 5-methylcytosine (5mC) respectively, plays crucial roles in diverse biological processes. Currently, there is a lack of knowledge regarding the cross-talk between m6A and 5mC regulators. Thus, we systematically...

Full description

Bibliographic Details
Main Authors: Yu-Tong Chen, Jia-Yi Shen, Dong-Ping Chen, Chen-Fei Wu, Rui Guo, Pan-Pan Zhang, Jia-Wei Lv, Wen-Fei Li, Zi-Xian Wang, Yu-Pei Chen
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13045-020-00854-w
_version_ 1818030149777489920
author Yu-Tong Chen
Jia-Yi Shen
Dong-Ping Chen
Chen-Fei Wu
Rui Guo
Pan-Pan Zhang
Jia-Wei Lv
Wen-Fei Li
Zi-Xian Wang
Yu-Pei Chen
author_facet Yu-Tong Chen
Jia-Yi Shen
Dong-Ping Chen
Chen-Fei Wu
Rui Guo
Pan-Pan Zhang
Jia-Wei Lv
Wen-Fei Li
Zi-Xian Wang
Yu-Pei Chen
author_sort Yu-Tong Chen
collection DOAJ
description Abstract Methylation of RNA and DNA, notably in the forms of N6-methyladenosine (m6A) and 5-methylcytosine (5mC) respectively, plays crucial roles in diverse biological processes. Currently, there is a lack of knowledge regarding the cross-talk between m6A and 5mC regulators. Thus, we systematically performed a pan-cancer genomic analysis by depicting the molecular correlations between m6A and 5mC regulators across ~ 11,000 subjects representing 33 cancer types. For the first time, we identified cross-talk between m6A and 5mC methylation at the multiomic level. Then, we further established m6A/5mC epigenetic module eigengenes by combining hub m6A/5mC regulators and informed a comprehensive epigenetic state. The model reflected status of the tumor-immune-stromal microenvironment and was able to predict patient survival in the majority of cancer types. Our results lay a solid foundation for epigenetic regulation in human cancer and pave a new road for related therapeutic targets.
first_indexed 2024-12-10T05:31:00Z
format Article
id doaj.art-994786b145ba465b9d7b966534924918
institution Directory Open Access Journal
issn 1756-8722
language English
last_indexed 2024-12-10T05:31:00Z
publishDate 2020-03-01
publisher BMC
record_format Article
series Journal of Hematology & Oncology
spelling doaj.art-994786b145ba465b9d7b9665349249182022-12-22T02:00:33ZengBMCJournal of Hematology & Oncology1756-87222020-03-011311510.1186/s13045-020-00854-wIdentification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer typesYu-Tong Chen0Jia-Yi Shen1Dong-Ping Chen2Chen-Fei Wu3Rui Guo4Pan-Pan Zhang5Jia-Wei Lv6Wen-Fei Li7Zi-Xian Wang8Yu-Pei Chen9State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterAbstract Methylation of RNA and DNA, notably in the forms of N6-methyladenosine (m6A) and 5-methylcytosine (5mC) respectively, plays crucial roles in diverse biological processes. Currently, there is a lack of knowledge regarding the cross-talk between m6A and 5mC regulators. Thus, we systematically performed a pan-cancer genomic analysis by depicting the molecular correlations between m6A and 5mC regulators across ~ 11,000 subjects representing 33 cancer types. For the first time, we identified cross-talk between m6A and 5mC methylation at the multiomic level. Then, we further established m6A/5mC epigenetic module eigengenes by combining hub m6A/5mC regulators and informed a comprehensive epigenetic state. The model reflected status of the tumor-immune-stromal microenvironment and was able to predict patient survival in the majority of cancer types. Our results lay a solid foundation for epigenetic regulation in human cancer and pave a new road for related therapeutic targets.http://link.springer.com/article/10.1186/s13045-020-00854-wm6A regulators5mC regulatorsPan-cancer analysesGenomic alterationsTumor microenvironmentSurvival
spellingShingle Yu-Tong Chen
Jia-Yi Shen
Dong-Ping Chen
Chen-Fei Wu
Rui Guo
Pan-Pan Zhang
Jia-Wei Lv
Wen-Fei Li
Zi-Xian Wang
Yu-Pei Chen
Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
Journal of Hematology & Oncology
m6A regulators
5mC regulators
Pan-cancer analyses
Genomic alterations
Tumor microenvironment
Survival
title Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
title_full Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
title_fullStr Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
title_full_unstemmed Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
title_short Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
title_sort identification of cross talk between m6a and 5mc regulators associated with onco immunogenic features and prognosis across 33 cancer types
topic m6A regulators
5mC regulators
Pan-cancer analyses
Genomic alterations
Tumor microenvironment
Survival
url http://link.springer.com/article/10.1186/s13045-020-00854-w
work_keys_str_mv AT yutongchen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT jiayishen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT dongpingchen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT chenfeiwu identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT ruiguo identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT panpanzhang identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT jiaweilv identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT wenfeili identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT zixianwang identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes
AT yupeichen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes